ConCallIQ
Go Pro

DOMS Industries FY26 Annual Earnings Summary

3 quarters covered · ₹1,722 Cr revenue · ₹181 Cr PAT · 17.5% average EBITDA margin.

Total annual revenue: ₹1,722 Cr
Annual PAT: ₹181 Cr
Average margin: 17.5%
Promise delivery: 0%

Quarter-by-quarter progression

QuarterRevenuePATMarginSentiment
Q1 FY26₹562 Cr₹59 Cr17.6%bullish
Q2 FY26₹568 Cr₹61 Cr17.5%bullish
Q3 FY26₹592 Cr₹61 Cr17.5%bullish

Management promises made during the year

FY26 revenue growth guidance of 18-20%

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q2 FY26
missed
FY26 EBITDA margin guidance of 16.5%-17.5%

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q2 FY26
missed
First building of 44-acre project by Q3 FY26

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q2 FY26
missed
FY26 revenue growth guidance maintained at 18-20%

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY26
missed
EBITDA margin guidance of 16.5-17.5%

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY26
missed
Capex guidance of ₹210-225 crore for FY26

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY26
missed

Risks flagged during the year

Q1 FY26 · high

Timely completion of the 44-acre project and other expansions is critical to meet demand; any delay could constrain growth.

Q1 FY26 · medium

US tariffs on core export products could rise to ~50.65%, but exposure is only 5.5-5.8% of sales; management expects offset from other markets.

Q2 FY26 · medium

US tariffs introduced in September may reduce export orders; management has diverted capacity to other markets but impact is uncertain.

Q2 FY26 · medium

Scholastic stationary and art material growth was only ~4% YoY due to lack of capacity additions; new capacity only from Q1 FY27.

Q3 FY26 · medium

Input costs for key raw materials like polymers and waxes are trending upwards, which could pressure margins if sustained. Management is monitoring and may adjust pricing if needed.

Q3 FY26 · medium

Exports of wooden pencils to the US have declined significantly due to 50% tariffs, affecting the scholastic stationary segment. Recovery depends on tariff normalization.

Q1 FY26 · low

Potential shortage of poplar wood from Kashmir due to geopolitical issues; management maintains 6-month inventory buffers.

Q2 FY26 · low

GST rate reduction to 0% on ~45% of products caused temporary inventory clearance and order postponement, impacting Q2 sales by 3-4%.

Q2 FY26 · low

Employee costs rose 85 bps as a percentage of sales due to advance hiring for expansion and GST disruption; operating leverage may be delayed.

Q3 FY26 · low

Construction delays due to unseasonal monsoon have pushed back commercial production to Q2 FY27. Further delays could impact capacity expansion timelines.

Q3 FY26 · low

UniLand's EBITDA margins spiked to 12% in Q3 due to winter seasonality, but full-year margins are expected at 8-9%. Q1 is typically weak, leading to quarterly volatility.

What changed through the year

G

Q1 FY26 · FY26 revenue growth guidance of 18-20%

Management reiterated revenue growth guidance of 18-20% for FY26, despite Q1 coming in higher at 26.4% due to UniLand consolidation.

G

Q1 FY26 · FY26 EBITDA margin guidance of 16.5%-17.5%

EBITDA margin guidance maintained at 16.5%-17.5% for FY26, with Q1 margin at 17.6% trending towards the upper end.

G

Q1 FY26 · FY26 capex of ₹210-225 crore

Capex for FY26 expected to be ₹210-225 crore, primarily for the 44-acre project and capacity additions across segments.

G

Q1 FY26 · First building of 44-acre project by Q3 FY26

First building handover expected by end of Q3 FY26, with commercial production starting ~90 days later in Q4.

G

Q2 FY26 · FY26 revenue growth guidance maintained at 18-20%

Management reiterated full-year revenue growth guidance of 18-20%, noting that H1 growth was boosted by full consolidation of Unigland Healthcare.

G

Q2 FY26 · EBITDA margin guidance of 16.5-17.5%

Management expects EBITDA margins to remain in the 16.5-17.5% range, supported by operational efficiencies.

G

Q2 FY26 · Capex guidance of ₹210-225 crore for FY26

Consolidated capex of ~₹150 crore in H1 FY26; full-year capex expected in the ₹210-225 crore range.

G

Q2 FY26 · 44-acre plant commercial production from Q1 FY27

First building possession expected in Q4 FY26, with commercial production starting in Q1 FY27, initially for pencil capacity.

G

Q3 FY26 · FY26 revenue growth guidance of 18-20%

Management expects to close FY26 at the upper end of the guided revenue growth range of 18-20%, with 9M growth already at 22.7%.

G

Q3 FY26 · FY27 revenue growth guidance of 18-20%

For FY27, management targets similar revenue growth of 18-20%, driven by volume growth from new capacities and full utilization of recent brownfield expansions.

G

Q3 FY26 · Capex guidance of ₹225-250 crore for FY27

Capital expenditure for FY27 is expected to be between ₹225-250 crore, similar to FY26 levels, primarily for the 44-acre greenfield project.

G

Q3 FY26 · First building commercial production in Q2 FY27

Commercial production from the first building of the 44-acre project is expected to start in Q2 FY27, with subsequent buildings coming online over the next 9 quarters.